Sanofi and Translate Bio Expand Collaboration to Develop mRNA Vaccines Across All Infectious Disease Areas
Translate Bio to receive $425 million in upfront payment and common stock equity investment and overall is eligible to receive up to $1.9 billion of potential milestones/payments as well as tiered royalties on worldwide sales of developed vaccines
Sanofi...
The Company will present and host one-on-one meetings at the following virtual investment banking conferences:
Bank of America Healthcare Conference 2020, May 12-15, 2020
Jefferies Virtual Healthcare Conference, June 2-4, 2020
It hit the trend resistance, rsi broke the trend though. This stock would be healthy after it broke $13. However, weekly volume is well above average for two weeks.
This looks like a promising setup. I haven't done any DD on the company's fundamentals, pipeline, etc., but just looking at the chart this seems poised for a squeeze release. Do you own DD and GLTA
TBIO had a wonderful move & now consolidating within a Pennant formation. If it can breakout $1.90 it can easily hit $140 & higher.
* Trade Criteria *
Date first found- February 9, 2017
Pattern/Why- Breakout trade, Pennant formation.
Entry Target Criteria- Break of $0.90
Exit Target Criteria- First target $1.20, Second target $1.40
Stop Loss Criteria- N/A...
